Suzhou Fushilai Pharmaceutical (301258.SZ) obtained the registration certificate for L-cysteine tablets.

date
15:55 09/12/2025
avatar
GMT Eight
Fuji Lei (301258.SZ) announcement, the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for thioparcacid tablets. Indication of thioparcacid tablets: Used for sensory abnormalities caused by diabetic peripheral neuropathy.
Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Lipoic Acid Tablets. The indications for Lipoic Acid Tablets are: used for sensory abnormalities caused by peripheral neuropathy in diabetes.